Cargando…

Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain

Since the COVID-19 pandemic onset, the antibody response to SARS-CoV-2 has been extensively characterized. Antibodies to the receptor binding domain (RBD) on the spike protein are frequently encoded by IGHV3-53/3-66 with a short CDR H3. Germline-encoded sequence motifs in CDRs H1 and H2 play a major...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Timothy J.C., Yuan, Meng, Kuzelka, Kaylee, Padron, Gilberto C., Beal, Jacob R., Chen, Xin, Wang, Yiquan, Rivera-Cardona, Joel, Zhu, Xueyong, Stadtmueller, Beth M., Brooke, Christopher B., Wilson, Ian A., Wu, Nicholas C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852275/
https://www.ncbi.nlm.nih.gov/pubmed/33532781
http://dx.doi.org/10.1101/2021.01.26.428356
_version_ 1783645789211328512
author Tan, Timothy J.C.
Yuan, Meng
Kuzelka, Kaylee
Padron, Gilberto C.
Beal, Jacob R.
Chen, Xin
Wang, Yiquan
Rivera-Cardona, Joel
Zhu, Xueyong
Stadtmueller, Beth M.
Brooke, Christopher B.
Wilson, Ian A.
Wu, Nicholas C.
author_facet Tan, Timothy J.C.
Yuan, Meng
Kuzelka, Kaylee
Padron, Gilberto C.
Beal, Jacob R.
Chen, Xin
Wang, Yiquan
Rivera-Cardona, Joel
Zhu, Xueyong
Stadtmueller, Beth M.
Brooke, Christopher B.
Wilson, Ian A.
Wu, Nicholas C.
author_sort Tan, Timothy J.C.
collection PubMed
description Since the COVID-19 pandemic onset, the antibody response to SARS-CoV-2 has been extensively characterized. Antibodies to the receptor binding domain (RBD) on the spike protein are frequently encoded by IGHV3-53/3-66 with a short CDR H3. Germline-encoded sequence motifs in CDRs H1 and H2 play a major role, but whether any common motifs are present in CDR H3, which is often critical for binding specificity, have not been elucidated. Here, we identify two public clonotypes of IGHV3-53/3-66 RBD antibodies with a 9-residue CDR H3 that pair with different light chains. Distinct sequence motifs on CDR H3 are present in the two public clonotypes that appear to be related to differential light chain pairing. Additionally, we show that Y58F is a common somatic hypermutation that results in increased binding affinity of IGHV3-53/3-66 RBD antibodies with a short CDR H3. Overall, our results advance fundamental understanding of the antibody response to SARS-CoV-2.
format Online
Article
Text
id pubmed-7852275
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-78522752021-02-03 Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain Tan, Timothy J.C. Yuan, Meng Kuzelka, Kaylee Padron, Gilberto C. Beal, Jacob R. Chen, Xin Wang, Yiquan Rivera-Cardona, Joel Zhu, Xueyong Stadtmueller, Beth M. Brooke, Christopher B. Wilson, Ian A. Wu, Nicholas C. bioRxiv Article Since the COVID-19 pandemic onset, the antibody response to SARS-CoV-2 has been extensively characterized. Antibodies to the receptor binding domain (RBD) on the spike protein are frequently encoded by IGHV3-53/3-66 with a short CDR H3. Germline-encoded sequence motifs in CDRs H1 and H2 play a major role, but whether any common motifs are present in CDR H3, which is often critical for binding specificity, have not been elucidated. Here, we identify two public clonotypes of IGHV3-53/3-66 RBD antibodies with a 9-residue CDR H3 that pair with different light chains. Distinct sequence motifs on CDR H3 are present in the two public clonotypes that appear to be related to differential light chain pairing. Additionally, we show that Y58F is a common somatic hypermutation that results in increased binding affinity of IGHV3-53/3-66 RBD antibodies with a short CDR H3. Overall, our results advance fundamental understanding of the antibody response to SARS-CoV-2. Cold Spring Harbor Laboratory 2021-01-27 /pmc/articles/PMC7852275/ /pubmed/33532781 http://dx.doi.org/10.1101/2021.01.26.428356 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.
spellingShingle Article
Tan, Timothy J.C.
Yuan, Meng
Kuzelka, Kaylee
Padron, Gilberto C.
Beal, Jacob R.
Chen, Xin
Wang, Yiquan
Rivera-Cardona, Joel
Zhu, Xueyong
Stadtmueller, Beth M.
Brooke, Christopher B.
Wilson, Ian A.
Wu, Nicholas C.
Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain
title Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain
title_full Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain
title_fullStr Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain
title_full_unstemmed Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain
title_short Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain
title_sort sequence signatures of two ighv3-53/3-66 public clonotypes to sars-cov-2 receptor binding domain
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852275/
https://www.ncbi.nlm.nih.gov/pubmed/33532781
http://dx.doi.org/10.1101/2021.01.26.428356
work_keys_str_mv AT tantimothyjc sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain
AT yuanmeng sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain
AT kuzelkakaylee sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain
AT padrongilbertoc sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain
AT bealjacobr sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain
AT chenxin sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain
AT wangyiquan sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain
AT riveracardonajoel sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain
AT zhuxueyong sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain
AT stadtmuellerbethm sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain
AT brookechristopherb sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain
AT wilsoniana sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain
AT wunicholasc sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain